Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -183.87M | -18387.4% | $ 1M |
3/31/2025 | $ -153.16M | -15315.9% | $ 1M |
12/31/2024 | $ -130.93M | -13092.7% | $ 1M |
9/30/2024 | $ -95.24M | -9524.4% | $ 1M |
6/30/2024 | $ -100.98M | 0% | $ 0 |
3/31/2024 | $ -113.99M | 0% | $ 0 |
12/31/2023 | $ -118.24M | -3284.53% | $ 3.6M |
9/30/2023 | $ -126.11M | -3503.14% | $ 3.6M |
6/30/2023 | $ -133.36M | -3704.42% | $ 3.6M |
3/31/2023 | $ -145.61M | -4044.78% | $ 3.6M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: EBIT [ $ -98.8M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |